From pig to patient Pioneering transplants from pigs to humans could mark a turning point for organ replacement. Written byAndrea Corona

https://www.drugdiscoverynews.com/from-pig-to-patient-16896?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9Kdpv8fqN7BJeaJy7zEesF8mMHlKlDo2SQjkDaY8fFZoXk-AAj4cU2Hdil2c3gK4H-9Nvg32AUE8a1L1AjMFku4x8q4w&_hsmi=419757017&utm_content=419757017&utm_source=hs_email Tim Andrews, 67, has now lived more than eight months with a genetically-engineered pig kidney, making him the longest-living human recipient of such an organ to date. Discharged from dialysis and thriving, he stands at the vanguard of a shift in transplantation science. At the same time, biotechnology firm eGenesis has just won FDA clearance to begin a full clinical trial of its porcine kidney candidate EGEN-2784. Together, these developments mark what may be a turning point with xenotransplantation no longer being speculative science, but a nascent therapy entering human trials.